Intensive Care Medicine

, Volume 33, Issue 1, pp 190–194 | Cite as

Effects of low-dose naloxone on opioid therapy in pediatric patients: a retrospective case-control study

  • C. L. S. Cheung
  • M. van Dijk
  • J. W. Green
  • D. Tibboel
  • K. J. S. AnandEmail author
Pediatric Brief Report



To develop novel therapies that prevent opioid tolerance in critically ill children we examined the effects of low-dose naloxone infusions on patients' needs for analgesia or sedation.

Design and setting

Matched case-control study in a pediatric intensive care unit at a university children's hospital.


We compared 14 pediatric ICU patients receiving low-dose naloxone and opioid infusions with 12 matched controls receiving opioid infusions.

Measurements and main results

Opioid analgesia and sedative requirements were assessed as morphine- and midazolam-equivalent doses, respectively. No differences were observed between groups in opioid doses at baseline or during naloxone, but in the postnaloxone period opioid doses tended to be lower in the naloxone group. Compared to baseline the naloxone group required more opioids during naloxone but fewer opioids after naloxone. Total sedative doses were comparable at baseline in both groups, with no differences in the postnaloxone period. The naloxone group required less sedation after naloxone but sedation doses were unchanged in controls. The two groups did not differ in pain scores, sedation scores, or opioid side effects.


Naloxone did not reduce the need for opioid during the infusion period but tended to reduce opioid requirements in the postnaloxone period without additional need for sedation. Randomized clinical trials may examine the effects of low-dose naloxone on opioid tolerance and side effects in pediatric ICU patients requiring prolonged opioid analgesia.


Opioid Tolerance Addiction Neuroadaptation Sedation 



The authors thank J.M. Tilford, Ph.D. for help with PRISM analyses. The work was performed at Arkansas Children's Hospital Research Institute.

Supplementary material

134_2006_387_MOESM1_ESM.doc (66 kb)
Electronic Supplementary Material (DOC 66K)


  1. 1.
    Siddappa R, Fletcher JE, Heard AM, Kielma D, Cimino M, Heard CM (2003) Methadone dosage for prevention of opioid withdrawal in children. Paediatr Anaesth 13:805–810PubMedCrossRefGoogle Scholar
  2. 2.
    Tobias JD (2000) Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med 28:2122–2132PubMedCrossRefGoogle Scholar
  3. 3.
    Berde CB, Sethna NF (2002) Analgesics for the treatment of pain in children. N Engl J Med 347:1094–1103PubMedCrossRefGoogle Scholar
  4. 4.
    Fonsmark L, Rasmussen YH, Carl P (1999) Occurrence of withdrawal in critically ill sedated children. Crit Care Med 27:196–199PubMedCrossRefGoogle Scholar
  5. 5.
    Katz R, Kelly HW, Hsi A (1994) Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Crit Care Med 22:763–767PubMedCrossRefGoogle Scholar
  6. 6.
    Crain SM, Shen KF (2000) Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain 84:121–131PubMedCrossRefGoogle Scholar
  7. 7.
    Crain SM, Shen KF (1998) Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions. Trends Pharmacol Sci 19:358–365PubMedCrossRefGoogle Scholar
  8. 8.
    Lee J, Shim JY, Choi JH, Kim ES, Kwon OK, Moon DE, Choi JH, Bishop MJ (2001) Epidural naloxone reduces intestinal hypomotility but not analgesia of epidural morphine. Can J Anaesth 48:54–58PubMedCrossRefGoogle Scholar
  9. 9.
    Gan TJ, Ginsberg B, Glass PS, Fortney J, Jhaveri R, Perno R (1997) Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology 87:1075–1081PubMedCrossRefGoogle Scholar
  10. 10.
    Lehmann KA, Reichling U, Wirtz R (1988) Influence of naloxone on the postoperative analgesic and respiratory effects of buprenorphine. Eur J Clin Pharmacol 34:343–352PubMedCrossRefGoogle Scholar
  11. 11.
    Liu JG, Anand KJS (2001) Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev 38:1–19PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • C. L. S. Cheung
    • 1
  • M. van Dijk
    • 1
  • J. W. Green
    • 2
  • D. Tibboel
    • 1
  • K. J. S. Anand
    • 2
    • 3
    Email author
  1. 1.Department of Pediatric Surgery, University Medical Center and Erasmus MCSophia Children’s HospitalRotterdamThe Netherlands
  2. 2.Department of Pediatrics, College of MedicineUniversity of Arkansas and Arkansas Children’s HospitalLittle RockUSA
  3. 3.Departments of Anesthesiology, Neurobiology and Pharmacology, College of Medicine, Medical SchoolUniversity of Arkansas and Arkansas Children’s HospitalLittle RockUSA

Personalised recommendations